Abstract
Here, we describe a clinical case involving a 19-year-old male diagnosed with schizophrenia and initiated on risperidone 2 mg/day. The dose was gradually built up to 6 mg/day. Within a week, the patient manifested an extensive exanthematous eruption characterized by collarette-shaped desquamation and intense pruritus. The medication was promptly discontinued, and aripiprazole was introduced, resulting in the complete resolution of the cutaneous manifestations within the subsequent week.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
